Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net income (loss)	$ (7,332)	$ (8,967)	$ 7,406
Adjustments to reconcile to net cash used in operating activities:
Depreciation and amortization	74,376	63,588	45,186
Amortization of debt issuance costs	2,922	2,420	1,888
Extinguishment of debt	0	0	3,395
Stock-based compensation	5,233	7,940	2,448
Compensation expense related to employee share purchases	0	427	0
Deferred income taxes	(6,649)	(8,028)	(2,406)
Change in fair value of earnout liabilities	988	(758)	483
(Gain) loss on sale of rental equipment	(2,813)	(2,675)	(3,632)
(Gain) loss on sale of property, plant and equipment	(61)	294	0
Charge for step-up of acquired inventory	2,882	3,582	2,866
Net realizable value adjustment and write-offs for obsolete and excess inventory	6,612	8,990	4,608
Bad debt expense	863	784	795
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(1,423)	18,020	(21,771)
Inventories	(9,227)	(1,236)	(42,404)
Prepaid expenses and other current assets	(869)	931	(1,874)
Accounts payable	11,338	3,048	(8,839)
Accrued expenses and other current liabilities	(21,254)	13,667	4,492
Other changes in operating assets and liabilities	867	259	(3,670)
Net cash provided by (used in) operating activities	56,453	102,286	(11,029)
Investing activities
Purchases of property, plant and equipment	(13,684)	(15,337)	(8,307)
Proceeds from sale of property, plant and equipment	3,662	0	0
Business acquisitions, net of cash acquired	(199,423)	(259,835)	(115,343)
Asset acquisitions	(15,853)	0	0
Purchases of rental equipment	(9,509)	(9,341)	(11,794)
Proceeds from sale of rental equipment	5,124	5,990	8,756
Net cash provided by (used in) investing activities	(229,683)	(278,523)	(126,688)
Financing activities
Proceeds from revolving lines of credit	211,599	180,982	383,489
Payments on revolving lines of credit	(213,634)	(302,083)	(320,751)
Proceeds from term loans	200,000	305,000	445,630
Payments on term loans	(32,750)	(26,375)	(335,305)
Deferred financing costs	(2,064)	(3,419)	(11,956)
Proceeds from rights offering, net of offering costs of $1,531	0	98,469	0
Repurchase of common stock	(2,580)	(3,619)	(1,940)
Shares repurchased held in treasury	(617)	(287)	(520)
Proceeds from employees for share purchases	0	3,253	0
Payment of financing lease principal	(653)	(515)	(429)
Payment of earnout	0	(1,000)	0
Payment on seller's note	0	0	(9,757)
Net cash provided by (used in) financing activities	159,301	250,406	148,461
Effect of exchange rate changes on cash and cash equivalents	(3,971)	717	(675)
Increase (decrease) in cash, cash equivalents and restricted cash	(17,900)	74,886	10,069
Cash, cash equivalents and restricted cash at beginning of period	99,626	24,740	14,671
Cash, cash equivalents and restricted cash at end of period	81,726	99,626	24,740
Cash and cash equivalents	66,479	83,931	24,554
Restricted cash	15,247	15,695	186
Total cash, cash equivalents and restricted cash	81,726	99,626	24,740
Supplemental disclosure of cash flow information
Net cash paid for income taxes	15,259	12,422	13,813
Net cash paid for interest	52,905	38,048	22,153
Net cash paid for interest on supply chain financing	2,889	2,581	1,291
Non-cash activities:
Fair value of common stock exchanged for reverse acquisition	0	0	351,491
Settlement of related party obligations	0	0	5,276
Additions of property, plant and equipment included in accounts payable	457	361	177
Right of use assets obtained in exchange for finance lease liabilities	821	616	886
Right of use assets obtained in exchange for operating lease liabilities	14,515	19,424	14,634
Seller's note issued as purchase consideration	$ 0	$ 0	$ 1,169